Rein Therapeutics (RNTX) Q2 2026 Earnings

15MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.49
-0.39
-0.29
-0.19

Details

Expected EPS
-0.49
Actual EPS
-0.19
Surprise EPS
0.3
Surprise Percent
+61.22%

Description

Rein Therapeutics (RNTX) has reported earnings of -0.19 per share for Q2 2026.

0 Comments

Share your thoughts